Gb virus c (hepatitis g virus) for the treatment of hiv
AssigneesUniversity of Iowa Research Foundation, The United States of America, as represented by the Secretary, Department of
InventorsJack T. STAPLETON, Jinhua XIANG, Donna KLINZMAN, James H. McLINDEN
Life of this patent
Estimating the term…
Abstract
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
Claims17
1-27. (canceled)
A vaccine composition comprising a GBV-C E2 polypeptide or peptide dispersed in pharmaceutical carrier, buffer or medium.
A method of immunizing a subject comprising contacting said subject with a vaccine composition comprising a GBV-C E2 polypeptide or peptide dispersed in a pharmaceutical carrier, buffer or medium.
Dependencies are inferred from the claim text.